Tuesday, April 16, 2024
Home Tags Metastatic urothelial carcinoma

Tag: metastatic urothelial carcinoma

First dose administered in Efti, BAVENCIO trial for metastatic urothelial cancer

Immutep Limited, a pioneering clinical-stage biotechnology company specializing in LAG-3 immunotherapies, announced the enrollment and safe dosing of the first patient in the INSIGHT-005 Phase I trial in the fight against metastatic urothelial carcinoma.
Advertisement

Bits Orchestra

Manufacturing Catalyst

Featured Article

Sydney to spotlight the latest in manufacturing at AMW 2024

With the Australian Manufacturing Week (AMW) 2024 fast approaching, Sydney is set to become the epicentre of groundbreaking innovations in the advanced manufacturing sector.